GZR101

· Gan and Lee Pharmaceuticals, USA

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GZR101, covering 2024-08-16 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM [Phase 2]

See pricing